Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Other Non-Current Assets (2021 - 2025)

Roivant Sciences' Other Non-Current Assets history spans 5 years, with the latest figure at $34.6 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets changed N/A year-over-year to $34.6 million; the TTM value through Dec 2025 reached $34.6 million, changed N/A, while the annual FY2025 figure was $32.9 million, 12.84% down from the prior year.
  • Other Non-Current Assets reached $34.6 million in Q4 2025 per ROIV's latest filing, up from $27.8 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $86.6 million in Q1 2021 to a low of $8.9 million in Q3 2021.
  • Average Other Non-Current Assets over 5 years is $33.7 million, with a median of $32.9 million recorded in 2025.
  • Peak YoY movement for Other Non-Current Assets: crashed 70.19% in 2022, then skyrocketed 349.54% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $11.9 million in 2021, then surged by 290.0% to $46.2 million in 2022, then rose by 1.35% to $46.8 million in 2023, then dropped by 21.23% to $36.9 million in 2024, then decreased by 6.34% to $34.6 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Other Non-Current Assets are $34.6 million (Q4 2025), $27.8 million (Q3 2025), and $31.1 million (Q2 2025).